Beyond Air (XAIR) Return on Invested Capital (2017)

Beyond Air (XAIR) reported Return on Invested Capital of 0.88% for Q4 2017, up 210.46% sequentially from 0.79% in Q3 2017.

Beyond Air (XAIR) Return on Invested Capital (2017) Analysis & Trends

Beyond Air (XAIR) has 1 years of Return on Invested Capital data on file, last reported at 0.88% in Q4 2017.

For the quarter ending Q4 2017, Return on Invested Capital changed N/A year-over-year to 0.88%; the trailing twelve-month figure through Dec 2017 stood at 0.88% (changed N/A YoY), and the FY2026 full-year result was 0.45%, changed N/A from the prior year.
Return on Invested Capital advanced to 0.88% in Q4 2017, from 0.79% in the prior quarter.
In the past five years, Return on Invested Capital ranged from a high of 0.88% in Q4 2017 to a low of 0.79% in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.01%
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.01%
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.01%
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.00%
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.00%
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Beyond Air	2.25 Mn	-10.02 Mn	94,000.00	-

Download Data